Product analysis
Natural E-Oil provides vitamin E in a clearly identified natural form at a favourable cost. Routine vitamin E use has no clear general role in cardiovascular support.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality100
The natural vitamin E form has favourable form-quality support. Its clear identification allows a direct comparison with other vitamin E options.
Ingredient Transparency100
The vitamin E amount and form are both disclosed. That makes the serving straightforward to check and compare.
Value For Money100
The natural vitamin E form offers favourable value at the serving price. Price appeal does not establish a cardiovascular benefit.
Customer Satisfaction84
Customer ratings are generally positive across a large number of reviews. The feedback gives a broad picture of satisfaction without proving health benefits.
Product Focus30
The formula stays focused on vitamin E. Routine supplementation has no clear general cardiovascular-support role.
- Format
Liquid - Container
- 1 Liquid(s)
- Per serving
- $0.13
- Also available
Natural E-Oil$11.60- Customer rating
- 4.6 · 3,064 ratings
Goals
Natural E-Oil declares 253 IU of D-alpha-tocopherol, but its usable cardiovascular amount is not established in the supplied facts. The cited human evidence did not show lower major cardiovascular-event incidence from routine vitamin E supplementation, leaving it without a clear general cardiovascular-support role.
How this product is rated for Cardiovascular Support
Ingredient fit56
Goal fit
Dose adequacy
Pathways0
Depth
Breadth
Evidence0
Evidence strength
Studied preparation
Formulation logic75
Partner coverage
Conflicts
Effective doses
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Vitamin E (D-Alpha-Tocopherol) | 253 IU |
How this ingredient is rated
Active Ingredient Quality & Bioavailability46
Natural (d-alpha) vs. Synthetic (dl-alpha)
Mixed Tocopherol Isomer Diversity
Tocotrienol Complex Inclusion
Dose, Safety & Label Transparency85
Therapeutic Dosage Range
Label Transparency and Isomer Specificity
Value100
Cost per Natural-Form Therapeutic Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
- Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
- Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
- Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
- Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
- Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
- Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan.
- Dietary carotenoids, vitamins C and E, and risk of cataract in women: a prospective study.
- Long-term nutrient intake and 5-year change in nuclear lens opacities.
- Dietary intake of antioxidants and risk of age-related macular degeneration.
- Effects of delta-tocotrienol supplementation on Glycemic Control, oxidative stress, inflammatory biomarkers and miRNA expression in type 2 diabetes mellitus: A randomized control trial.
- Effect of vitamin E supplementation on serum C-reactive protein level: a meta-analysis of randomized controlled trials.
- Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis.
- Vitamin E improves serum markers and histology in adults with metabolic dysfunction-associated steatotic liver disease: Systematic review and meta-analysis.
- Delta-tocotrienol supplementation improves biochemical markers of hepatocellular injury and steatosis in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled trial.